HomeAboutMediaCareersSite MapContactSearch
Geron
PatientsProductsTechnology & ScienceInvestors
print
  • Product Pipeline
  • News Releases
  • Annual Reports
  • Events
  • Corporate Governance
  • Information Request

Investor Contacts

Geron Corporation's common stock trades on The Nasdaq Stock Market under the symbol:

GERN (NASDAQ Stock Quote: 20 minute delay)


Media and Investor Relations

Noonan Russo

729 Seventh Avenue, 17th Floor
New York, NY 10019

Media Inquiries to: David Schull

Tel: 650-473-7765
Email: david.schull@eurorscg.com

Investor Inquiries to: Matthew Haines

Tel: 212-845-4235
Email: matthew.haines@eurorscg.com

General Inquiries to: Geron Corporation

230 Constitution Drive
Menlo Park, CA 94025
Tel: 650-473-7765
Email: info@geron.com

Transfer Agent & Registrar

U.S. Stock Transfer Corporation

1745 Gardena Avenue
Glendale, CA 91204-2991
Tel: 818-502-1404
Fax: 818-502-0674

Independent Auditors

Ernst & Young LLP

1001 Page Mill Road
Building 1, Suite 200
Palo Alto, CA 94304

Legal Counsel

Latham & Watkins LLP

140 Scott Drive
Menlo Park, CA 94025

Visionary Therapeutics
Home | About | Media | Careers | Site Map | Contact | Search
Patients | Products | Technology & Science | Investors
Legal Disclaimer
Copyright © Geron 2010. All rights reserved.